Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03266835 · ClinicalTrials.gov registry record · NA
SoundBite™ Crossing System Pivotal Peripheral CTO Crossing Study
A NA study, sponsored by SoundBite Medical Solutions.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT03266835: Completed NA study, sponsored by SoundBite Medical Solutions.
NCT03266835 is a NA study that has completed, run by SoundBite Medical Solutions. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03266835, a NA study, has completed, sponsored by SoundBite Medical Solutions.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
This study is aimed at demonstrating the efficacy and safety of the SoundBite™ Crossing System-Peripheral. The study is intended to demonstrate that the SoundBite™ Crossing System can facilitate the passage of either devices intended to treat a chronic total occlusion (CTO) or additional crossing devices through an infrainguinal CTO into the true lumen.
Primary Outcome
Ability to facilitate treatment of the target lesion by allowing additional crossing and/or treatment devices to cross the CTO
Interventions
- DEVICE SoundBite™ Crossing System - Peripheral
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2017-11-16 |
| Est. Completion | 2019-01-18 |
| Phase | NA |
What the finished NCT03266835 record still lists
NCT03266835 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which SoundBite™ Crossing System - Peripheral is the first listed.
NCT03266835 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03266835 about?
NCT03266835 is a clinical study titled "SoundBite™ Crossing System Pivotal Peripheral CTO Crossing Study". This study is aimed at demonstrating the efficacy and safety of the SoundBite™ Crossing System-Peripheral. The study is intended to demonstrate that the SoundBite™ Crossing System can facilitate the passage of either devices intended to treat a chronic total occlusion (CTO) or additional crossing de...
What is the current status of trial NCT03266835?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2017-11-16. Estimated completion is 2019-01-18.
What interventions are being tested in trial NCT03266835?
The interventions under investigation include: SoundBite™ Crossing System - Peripheral (DEVICE).
Who is sponsoring clinical trial NCT03266835?
This trial is sponsored by SoundBite Medical Solutions, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03266835's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI